Iohexol Inj 300 mg/mL
Iohexol Inj 300 mg/mL is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function
Clinical Trials (7)
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function
Description of the Evolution of Plasma and Urinary Concentrations of Iohexol in a Cirrhotic Patient Population
Iohexol for Measuring Renal Function
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7